Overview of key peptide research compounds including BPC-157, CJC-1295, Ipamorelin and GHK-Cu, with focus on...
GcMAF FRAG - 1mg, 10mg
€159.00
Tax excluded
IN-STOCK
GcMAF Frag (Gc protein–derived macrophage activating factor fragment) is a peptide fragment derived from vitamin D–binding protein (DBP) and studied for its interaction with macrophages, key cells of the innate immune system involved in immune surveillance and phagocytic processes. In experimental and preclinical research settings, GcMAF Frag has been investigated for its ability to influence macrophage-associated signaling pathways and immune-related functional markers. Within controlled laboratory models, exposure to GcMAF-related fragments has been associated with modulation of macrophage activity, including phagocytosis-related assays and cytokine-associated readouts. For this reason, the peptide is primarily used as a research tool in studies focused on immune regulation, inflammatory signaling, and host defense mechanisms. Chemical modifications such as N-terminal acetylation and C-terminal amidation have been evaluated in peptide research for their impact on structural stability and resistance to enzymatic degradation. In experimental systems, these features may contribute to enhanced molecular stability, prolonged functional persistence, and optimized receptor interaction profiles under in vitro conditions.